Marengo Therapeutics, Inc. is a biotechnology company focused on developing innovative cancer immunotherapies. The company is dedicated to harnessing the power of the immune system to target and eliminate cancer cells, aiming to provide new treatment options for patients with unmet medical needs.

Marengo Therapeutics is committed to sustainability and responsible business practices. However, specific information regarding their sustainability initiatives, such as ESG reports or carbon footprint calculations, is not readily available. The company may be in the early stages of developing a comprehensive sustainability strategy or may not have publicly disclosed detailed sustainability metrics at this time.

As a company operating in the biotechnology sector, Marengo Therapeutics is likely to focus on minimizing its environmental impact through efficient use of resources and waste management practices. Collaboration with partners and stakeholders to enhance sustainability efforts could be part of their long-term strategy.